GRI Bio (ADAIR Asset) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

GRI Bio (ADAIR Asset) General Information

Description

Abuse deterrent amphetamine immediate release and certain assets are located in La Jolla, United States. The company focuses on advancing its pipeline of novel assets in development for inflammatory and fibrotic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • La Jolla, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
Aardvark Therapeutics
Corporate Office
  • La Jolla, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GRI Bio (ADAIR Asset) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GRI Bio (ADAIR Asset)‘s full profile, request access.

Request a free trial

GRI Bio (ADAIR Asset) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GRI Bio (ADAIR Asset)‘s full profile, request access.

Request a free trial

GRI Bio (ADAIR Asset) FAQs

  • Where is GRI Bio (ADAIR Asset) headquartered?

    GRI Bio (ADAIR Asset) is headquartered in La Jolla, CA.

  • What industry is GRI Bio (ADAIR Asset) in?

    GRI Bio (ADAIR Asset)’s primary industry is Buildings and Property.

  • Is GRI Bio (ADAIR Asset) a private or public company?

    GRI Bio (ADAIR Asset) is a Private company.

  • What is the current valuation of GRI Bio (ADAIR Asset)?

    The current valuation of GRI Bio (ADAIR Asset) is .

  • What is GRI Bio (ADAIR Asset)’s current revenue?

    The current revenue for GRI Bio (ADAIR Asset) is .

  • Who are GRI Bio (ADAIR Asset)’s investors?

    GRI Bio has invested in GRI Bio (ADAIR Asset).

  • When was GRI Bio (ADAIR Asset) acquired?

    GRI Bio (ADAIR Asset) was acquired on 23-Aug-2023.

  • Who acquired GRI Bio (ADAIR Asset)?

    GRI Bio (ADAIR Asset) was acquired by Aardvark Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process